Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).

× No keyword cloud information.

14 in total

Review 1. Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors: Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal: World J Nephrol Date: 2016-09-06

Review 2. Bone Mineral Disease After Kidney Transplantation.

Authors: Josep-Vicent Torregrosa; Ana Carina Ferreira; David Cucchiari; Aníbal Ferreira
Journal: Calcif Tissue Int Date: 2021-03-25 Impact factor: 4.333

Review 3. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors: Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal: J Nephrol Date: 2017-04-21 Impact factor: 3.902

Review 4. Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.

Authors: Jorge B Cannata-Andía; Beatriz Martín-Carro; Julia Martín-Vírgala; Javier Rodríguez-Carrio; José Joaquín Bande-Fernández; Cristina Alonso-Montes; Natalia Carrillo-López
Journal: Calcif Tissue Int Date: 2020-11-15 Impact factor: 4.333

Review 5. Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.

Authors: Jordi Bover; Pablo Ureña; César Ruiz-García; Iara daSilva; Patricia Lescano; Jacqueline del Carpio; José Ballarín; Mario Cozzolino
Journal: Clin J Am Soc Nephrol Date: 2015-07-29 Impact factor: 8.237

6. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.

Authors: Xoana Barros; Nestor Y Rodríguez; David Fuster; Lida Rodas; Nuria Esforzado; Alberto Mazza; Domenico Rubello; Francisco Campos; Andrés Tapias; José-Vicente Torregrosa
Journal: J Nephrol Date: 2015-10-10 Impact factor: 3.902

7. Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis.

Authors: Blanca Gros; Antonio Galán; Emilio González-Parra; Jose A Herrero; Maria Echave; Stefan Vegter; Keith Tolley; Itziar Oyagüez
Journal: Health Econ Rev Date: 2015-06-11

Review 8. Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence.

Authors: M Jesús Lloret; César Ruiz-García; Iara Dasilva; Mónica Furlano; Yaima Barreiro; José Ballarín; Jordi Bover
Journal: Patient Prefer Adherence Date: 2013-11-06 Impact factor: 2.711

9. A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease.

Authors: Mariano Rodriguez; M Dolores Salmeron; Alejandro Martin-Malo; Carlo Barbieri; Flavio Mari; Rafael I Molina; Pedro Costa; Pedro Aljama
Journal: PLoS One Date: 2016-01-25 Impact factor: 3.240

10. Phosphate control in reducing FGF23 levels in hemodialysis patients.

Authors: Cristian Rodelo-Haad; Maria E Rodríguez-Ortiz; Alejandro Martin-Malo; M Victoria Pendon-Ruiz de Mier; M Luisa Agüera; Juan R Muñoz-Castañeda; Sagrario Soriano; Francisco Caravaca; M Antonia Alvarez-Lara; Arnold Felsenfeld; Pedro Aljama; Mariano Rodriguez
Journal: PLoS One Date: 2018-08-07 Impact factor: 3.240